These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 5479229)
1. [How does the information on drugs function in Norway. Question to the physicians]. Lunde PK Tidsskr Nor Laegeforen; 1970 Nov; 90(22):2103-4. PubMed ID: 5479229 [No Abstract] [Full Text] [Related]
2. [How doctors use and consider the various drug information sources available in Norway. Results from a general enquiry in 1970 and an additional enquiry in 1971]. Jenssen PG; Lunde PK Tidsskr Nor Laegeforen; 1972 Feb; 92(6):407-14. PubMed ID: 5021420 [No Abstract] [Full Text] [Related]
3. [Physicians' Union recommends centralization of information on drugs]. Lakartidningen; 1968 May; 65(21):2162-4. PubMed ID: 5725028 [No Abstract] [Full Text] [Related]
4. A physician looks at drug information. Keefer CS Am J Hosp Pharm; 1966 Feb; 23(2):55-9. PubMed ID: 5907112 [No Abstract] [Full Text] [Related]
5. Drug information for the physician. De Haen P N Y State J Med; 1970 Oct; 70(19):2475-80. PubMed ID: 5271794 [No Abstract] [Full Text] [Related]
6. [Information on embryotic risks]. Neubert D MMW Munch Med Wochenschr; 1984 Feb; 126(6):137-40. PubMed ID: 6423988 [No Abstract] [Full Text] [Related]
7. Dissemination of drug information. Henley S; Tester WW; Knapp R Hospitals; 1968 Jun; 42(12):99-102 passim. PubMed ID: 5652546 [No Abstract] [Full Text] [Related]
8. [Consumer protection or self-interest?]. Heinzl S Med Monatsschr Pharm; 2003 Apr; 26(4):109-10. PubMed ID: 12722524 [No Abstract] [Full Text] [Related]
9. [Self-assessment by physicians concerning their management of drug risks. Information sources, risk evaluation, problems and recommendations for improvements]. Kemmnitz W Z Arztl Fortbild Qualitatssich; 1998 Sep; 92(7):509-12. PubMed ID: 9842698 [TBL] [Abstract][Full Text] [Related]
11. [Adverse effects as sensations]. Haess K Tidsskr Nor Laegeforen; 1991 May; 111(14):1763-4. PubMed ID: 2063391 [No Abstract] [Full Text] [Related]
12. [Reporting of drug-induced complications]. Naess K Tidsskr Nor Laegeforen; 1965 Sep; 85(18):1413-5. PubMed ID: 5882532 [No Abstract] [Full Text] [Related]
13. [Organization of information on drugs]. Felipchuk IA; Iankhonen EN Aptechn Delo; 1966; 15(2):60-4. PubMed ID: 5997159 [No Abstract] [Full Text] [Related]
14. [The work of the Adverse Effects Committee]. Borchgrevink CF Tidsskr Nor Laegeforen; 1987 Mar; 107(9):871-3. PubMed ID: 3590130 [No Abstract] [Full Text] [Related]
15. [Adverse effects and the press]. Noess K Tidsskr Nor Laegeforen; 1992 Aug; 112(19):2557. PubMed ID: 1412271 [No Abstract] [Full Text] [Related]
16. [Drug interactions in an intensive care unit]. Nielsen EW; Dybwik K Tidsskr Nor Laegeforen; 2004 Nov; 124(22):2907-8. PubMed ID: 15550963 [TBL] [Abstract][Full Text] [Related]
17. [Drugs for children--when temporary solutions become routine]. Kalikstad B; Westergren T Tidsskr Nor Laegeforen; 2006 Mar; 126(7):930-2. PubMed ID: 16554887 [No Abstract] [Full Text] [Related]
18. [Registration of adverse effects and complications]. Asdahl T Tidsskr Nor Laegeforen; 1970 Nov; 90(22):2114-5. PubMed ID: 5479234 [No Abstract] [Full Text] [Related]